机构：[1]China Japan Friendship Hosp, Beijing, Peoples R China[2]Xijing Hosp, Xian, Peoples R China[3]Nanjing Drum Tower Hosp, Nanjing, Peoples R China[4]Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[5]Wuhan Union Hosp, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[6]Shanghai Changzheng Hosp, Shanghai, Peoples R China[7]Metab Dis Hosp, Tianjin, Peoples R China[8]Sun Yixian Commemorat Hosp, Guangzhou, Peoples R China
第一作者机构：[1]China Japan Friendship Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Yang Wenying,Ji Qiuhe,Zhu Dalong,et al.Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes[J].DIABETES RESEARCH AND CLINICAL PRACTICE.2008,79:S67-S67.doi:10.1016/S0168-8227(08)70807-6.
APA：
Yang, Wenying,Ji, Qiuhe,Zhu, Dalong,Yang, Jinkui,Chen, Lulu...&Yan, Li.(2008).Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes.DIABETES RESEARCH AND CLINICAL PRACTICE,79,
MLA：
Yang, Wenying,et al."Thrice daily biphasic insulin aspart 30 regimen: another therapeutic option for Chinese patients with Type 2 diabetes".DIABETES RESEARCH AND CLINICAL PRACTICE 79.(2008):S67-S67
